2023 AGENDA
All session times are in Eastern Time (ET)
7:45 am
7:45 am
NETWORKING BREAKFAST:BUILD COMMUNITY CONTACTS
8:45 am
8:45 am
OPENING COMMENTS FROM YOUR HOST
9:00 am
9:00 am
UPDATE FROM CADTH
Keep your Submission Strategy up to Date with the Latest Developments at CADTH
9:30 am
9:30 am
UPDATE FROM INESSS
Discover how INESSS Fits within Quebec’s Revised Life Sciences Strategy, its Impact on HTA in Canada and Market Access
10:00 am
10:00 am
KEYNOTE ADDRESS: NATIONAL STRATEGY FOR DRUGS FOR RARE DISEASES
Align your Market Access Plans with National Strategy Advances for Drugs for Rare Diseases
10:30 am
10:30 am
ROUNDTABLES → DISCOVER THOUGHT-PROVOKING IDEAS
11:00 am
11:00 am
KEYNOTE PANEL: MEETING FUTURE CHALLENGES
Is Canada Ready for the New Wave of Treatments?
11:45 am
11:45 am
PANEL DISCUSSION: THE EVOLUTION OF PATIENT SUPPORT PROGRAMS
Clarify your Market Access Plans with Insights on Patient Support Programs: Whose Responsibility are They, and How Should They be Run?
12:30 pm
12:30 pm
NETWORKING LUNCH:DELVE INTO INDUSTRY CONVERSATIONS
1:30 pm
1:30 pm
PANEL DISCUSSION: SWITCHING TO BIOSIMILARS
Incorporate the Latest Information on the Transition to Biosimilars into your Organizational Strategy
2:15 pm
2:15 pm
INDUSTRY EXPERT: INNOVATIVE NEW AGREEMENTS
Explore the New Types of Agreements and their Impact on Market Access Success
2:45 pm
2:45 pm
EXHIBITOR LOUNGE:ATTEND VENDOR DEMOS & CONSULT INDUSTRY EXPERTS
3:15 pm
3:15 pm
PANEL DISCUSSION: BOOSTING DOMESTIC DRUG SUPPLY
Increasing the Resiliency of our Drug Supply and Supply Chain to Prevent and Mitigate Shortages
4:00 pm
4:00 pm
PANEL DISCUSSION: HOW DOES CANADA RANK?
A Comparative Analysis of the Canadian Market for Market Access and New Start-ups
4:45 pm
4:45 pm
CLOSING COMMENTS FROM YOUR HOST
4:50 pm
4:50 pm